indans - CISMeF

Preferred Label : indans;

MeSH definition : Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.;

MeSH hyponym : indanones;

Codes EINECS : 207-814-7;

Is substance : O;

Details

Origin ID

D007189;

UMLS CUI

C0021184;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- [(6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-2-phenyl-1h-inden-5-yl)oxy]acetic acid [Substance BNPC]
CISMeF manual mappings
- Indan derivative (substance) [Inactive SNOMED CT concept]
Currated CISMeF NLP mapping
- Indan (substance) [SNOMED CT concept]
- indan [Substance BNPC]
Record concept(s)
- indanones [MeSH concept]
- indans [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((6,7-dichloro-2-(4-fluorophenyl)-2-methyl-1-oxo-5-indanyl)oxy)acetic acid [MeSH Supplementary Concept]
- (2R)-3-(2-aminomethyl-2,3-dihydro-1H-3a-azacyclopenta(a)inden-8-yl)-4-phenylaminopyrrole-2,5-dione monomethanesulphonate [MeSH Supplementary Concept]
- (2R)-pterosin P [MeSH Supplementary Concept]
- (2S,3S)-sulfated pterosin C [MeSH Supplementary Concept]
- (3-(3,4-dichlorophenyl)-4-methoxyindan-1-yl)methylamine [MeSH Supplementary Concept]
- (3-(3,4-dichlorophenyl)indan-1-yl)-4-methylpiperazine [MeSH Supplementary Concept]
- (5,6-dimethoxyindan-2-yl)dipropylamine [MeSH Supplementary Concept]
- (5-methoxy)donepezil [MeSH Supplementary Concept]
- (6,7-dimethoxy-2,4-dihydroindeno(1,2-c)pyrazol-3-yl)(3-fluorophenyl)amine [MeSH Supplementary Concept]
- (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate [MeSH Supplementary Concept]
- (N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl methyl carbamate [MeSH Supplementary Concept]
- (S)-5-(4-hydroxy-3,5-dimethyl-phenyl)-indan-1-ol [MeSH Supplementary Concept]
- 1,1-bis(4-aminobutyl)-6-benzylindane [MeSH Supplementary Concept]
- 1,1-dibenzyl-6-(4-aminobutyl)indane [MeSH Supplementary Concept]
- 1,1-dimethyl-5-(1-hydroxypropyl)-4,6,7-trimethylindan [MeSH Supplementary Concept]
- 1,1-dimethyl-5-nitro-3-(2-pyridon-1-yl)indan-2-ol [MeSH Supplementary Concept]
- 1,2-indandione [MeSH Supplementary Concept]
- 1,2-indanediol [MeSH Supplementary Concept]
- 1,2-indanedione [MeSH Supplementary Concept]
- 1,3-bis(4-iminobenzoic acid)indane [MeSH Supplementary Concept]
- 1,3-bis(dicyanomethylidene)indan [MeSH Supplementary Concept]
- 1,3-dioxoindane-2-carboxylic acid [MeSH Supplementary Concept]
- 1,3-indandione [MeSH Supplementary Concept]
- 1-(4-aminobutyl)-6-benzylindane [MeSH Supplementary Concept]
- 1-(4-fluorobenzyl)-4-((5,6-dimethoxy-1-oxoindan-2-fluoro-2-yl)methyl)piperidine [MeSH Supplementary Concept]
- 1-(4-fluorobenzyl)-4-((5,6-dimethoxy-1-oxoindan-2-yl)methyl)piperidine [MeSH Supplementary Concept]
- 1-(pyrrolidin-1-ylmethyl)-2-((6-chloro-3-oxoindan)formyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline [MeSH Supplementary Concept]
- 1-aminoindan [MeSH Supplementary Concept]
- 1-aminoindan-1,5-dicarboxylic acid [MeSH Supplementary Concept]
- 1-benzyl-6-(4-aminobutyl)indane [MeSH Supplementary Concept]
- 1-indanol [MeSH Supplementary Concept]
- 1-methoxy-6-(naphth-2-yl-methoxy)-1-(thiazol-2-yl)indan [MeSH Supplementary Concept]
- 1-methyl-5-phenyl-2,3,4,4a,5,9b-hexahydro-1H-indeno(1,2-b)pyridine [MeSH Supplementary Concept]
- 1-propyl-5-phenyl-2,3,4,4a,5,9b-hexahydro-1H-indeno(1,2-b)pyridine [MeSH Supplementary Concept]
- 1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)- [MeSH Supplementary Concept]
- 2,2-difluorobenzo(1,3)dioxole-5-carboxylic acid indan-2-ylamide [MeSH Supplementary Concept]
- 2,2-dihydroxyindane-1,3-dione [MeSH Supplementary Concept]
- 2,2-dimethylindan-1,3-dithione [MeSH Supplementary Concept]
- 2,2-dimethylindan-1-one-3-thione [MeSH Supplementary Concept]
- 2,3-dihydro-3-(4'-hydroxyphenyl)-1,1,3-trimethyl-1H-inden-5-ol [MeSH Supplementary Concept]
- 2,3-diphenyl-1-indanone [MeSH Supplementary Concept]
- 2,5-dibromo-2-(beta-naphthyl)indan-1,3-dione [MeSH Supplementary Concept]
- 2,6-dimethyl-1-oxo-4-indanecarboxylic acid [MeSH Supplementary Concept]
- 2-((1-oxyl-2,2,5,5-tetramethyl-3-pyrrolin-3-yl)methenyl)indane-1,3-dione [MeSH Supplementary Concept]
- 2-(2,3-dihydro-1H-inden-2-yl)-N-(1-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)acetamide [MeSH Supplementary Concept]
- 2-(2,4-dimethylphenyl)indan-1,3-dione [MeSH Supplementary Concept]
- 2-(2-(5-bromoindan-1-yl)-3-mercaptopropionylamino)-3-(1H-pyrrolo(2,3-b)pyridin-3-yl)propionic acid [MeSH Supplementary Concept]
- 2-(3,4-dihydro-2H-pyrrolium-1-yl)-3-oxoindan-1-olate [MeSH Supplementary Concept]
- 2-(4,6-difluoro-1-indanylidene)acetamide [MeSH Supplementary Concept]
- 2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol [MeSH Supplementary Concept]
- 2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide [MeSH Supplementary Concept]
- 2-(4-pyridylmethyl)-1-indanone [MeSH Supplementary Concept]
- 2-(indanyl)glycine [MeSH Supplementary Concept]
- 2-(n-butyl)-1-(N-methyl-N-(2-(N',N'-dimethylamino)ethyl)amino)-5,6-methylenedioxyindane [MeSH Supplementary Concept]
- 2-N,N-di-n-propylamino-4,7-dimethoxyindan [MeSH Supplementary Concept]
- 2-amino-4,6-dihydroxyindan [MeSH Supplementary Concept]
- 2-amino-4,7-dimethoxy-5-methylindan [MeSH Supplementary Concept]
- 2-aminoindan [MeSH Supplementary Concept]
- 2-aminoindan-2-phosphonic acid [MeSH Supplementary Concept]
- 2-benzyl-1-indanone [MeSH Supplementary Concept]
- 2-benzylidene-1-indanone [MeSH Supplementary Concept]
- 2-benzylidene-4,7-dimethylindan-1-one [MeSH Supplementary Concept]
- 2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one [MeSH Supplementary Concept]
- 2-butyl-3-(dimethylamino)-5,6-methylenedioxyindan [MeSH Supplementary Concept]
- 2-carboxyindan-1,3-dione [MeSH Supplementary Concept]
- 2-di-n-propylaminoindan [MeSH Supplementary Concept]
- 2-diazo-1-indanone [MeSH Supplementary Concept]
- 2-hydroxy-1-methylthioindane [MeSH Supplementary Concept]
- 2-indanol [MeSH Supplementary Concept]
- 2-indanylglycine [MeSH Supplementary Concept]
- 2-phenoxy-indan-1-one [MeSH Supplementary Concept]
- 2-piperazin-1-ylindan-2-carboxylic acid (3-chloro-5-fluorobenzyl)methylamide [MeSH Supplementary Concept]
- 2-pyridine-3-yl-methylene-indan-1,3-dione [MeSH Supplementary Concept]
- 3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate [MeSH Supplementary Concept]
- 3-(3',4',5'-trimethoxyphenyl)-4,5,6-trimethoxy,2-(3',4'-methylenedioxybenzylidene)indan-1-one [MeSH Supplementary Concept]
- 3-(3,4-dichlorophenyl)-6-hydroxy-N-methyl-1-indanamine [MeSH Supplementary Concept]
- 3-(4-(1- piperidinoethoxy)phenyl)spiro(indene- 1,1'-indane)-5,5'-diol [MeSH Supplementary Concept]
- 3-(methyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino)-1-indanone [MeSH Supplementary Concept]
- 3-ethoxy-3-(4-((4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)oxy)phenyl)propanoic acid [MeSH Supplementary Concept]
- 4(5)-((5-fluoroindan-2-yl)methyl)-4,5-dihydroimidazole [MeSH Supplementary Concept]
- 4,5,6,7-tetrachloroindan-1,3-dione [MeSH Supplementary Concept]
- 4,5-dichloro-1-aminioindan [MeSH Supplementary Concept]
- 4,7-dihydroxy-5-methyl-2-(2-oxopropyl)indan-1,3-dione [MeSH Supplementary Concept]
- 4-((1-hydroxy-2,3-dihydro-1H,1'H-(2,2-biinden)-2-yl)methyl)benzoic acid [MeSH Supplementary Concept]
- 4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-one-5-yl)oxybutyric acid [MeSH Supplementary Concept]
- 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol [MeSH Supplementary Concept]
- 4-(4-methylbenzoyl)-1-indancarboxylic acid [MeSH Supplementary Concept]
- 4-acetylaplykurodin B [MeSH Supplementary Concept]
- 4-amidinoindan-1-one 2'-amidinohydrazone [MeSH Supplementary Concept]
- 4-benzoyl-1-indancarboxylic acid [MeSH Supplementary Concept]
- 4-bromo-7-hydroxyindan oxime [MeSH Supplementary Concept]
- 4-hydroxy-2-(di-n-propylamino)indan [MeSH Supplementary Concept]
- 4-hydroxy-2-di-n-propylaminoindan [MeSH Supplementary Concept]
- 4-methoxy-2-(methylene propylamide)indan [MeSH Supplementary Concept]
- 4-methyl-1-((5-((3-oxo-3,4-dihydro-2H-benzo(1,4)oxazin-6-ylmethyl)carbamoyl)pyrazolo(1,5-a)pyrimidine-7-carbonyl)amino)indan-5-carboxylic acid [MeSH Supplementary Concept]
- 5,5'-bis(4-(2'-hydroxy-3'-methacryloyloxypropoxy)phenyl)hexahydro-4,7-methanoindan [MeSH Supplementary Concept]
- 5,5'6,6'-terahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobisindane [MeSH Supplementary Concept]
- 5,6-bis(dibenzyloxy)-1-oxo-2-propyl-2-indanpropionic acid [MeSH Supplementary Concept]
- 5,6-dihydroxy-2-(4-(methyl(propyl)amino)benzylidene)-2,3-dihydro-1H-inden-1-one [MeSH Supplementary Concept]
- 5,6-dimethoxy-1,2-indanedione [MeSH Supplementary Concept]
- 5,6-dimethoxy-1-indanone thiosemicarbazone [MeSH Supplementary Concept]
- 5,6-dimethoxyindan-1-acetic acid [MeSH Supplementary Concept]
- 5,6-dimethoxyindan-1-one [MeSH Supplementary Concept]
- 5,6-methylenedioxy-2-aminoindane [MeSH Supplementary Concept]
- 5,6-methylenedioxy-2-methylaminoindan [MeSH Supplementary Concept]
- 5-(3-(4-(4-fluorophenyl)-1-piperazinyl)propoxy)indan [MeSH Supplementary Concept]
- 5-(4-aminophenyl)-2,3,4,4a,5,9b-hexahydro-1H-indeno(1,2-b)pyridine [MeSH Supplementary Concept]
- 5-(6-cyano-1-hexen-2-yl)-7a-methyl-1-(6-methylhept-2-yl)hexahydroindan-4-acetic acid [MeSH Supplementary Concept]
- 5-acetyl-1,1,2,6-tetramethyl-3-isopropylindane [MeSH Supplementary Concept]
- 5-benzyloxy-1-oxo-2-butyl-2-indan propionic acid [MeSH Supplementary Concept]
- 5-desmethyl donepezil [MeSH Supplementary Concept]
- 5-iodo-2-aminoindan [MeSH Supplementary Concept]
- 5-methoxy-6-methyl-2-aminoindan [MeSH Supplementary Concept]
- 5-methylsulfonylamino-6-phenoxy-1-indanone [MeSH Supplementary Concept]
- 6,7-dihydro-1,1,2,3,3-pentamethyl-4-(5H)indanone [MeSH Supplementary Concept]
- 6-(2,3-dihydro-1,3-dioxo-2-phenyl-1H-inden-2-yl)-2,3-dihydroxybenzaldehyde [MeSH Supplementary Concept]
- 6-(N-alpha-pipecolinomethyl)-5-hydroxyindane [MeSH Supplementary Concept]
- 6-O-desmethyl donepezil [MeSH Supplementary Concept]
- 6-PMHIM [MeSH Supplementary Concept]
- 6-amino-2-(N, N-di-n-propylamino)thiazolo(4,5-f)indan [MeSH Supplementary Concept]
- 6-benzyl-1-(3-carboxypropyl)indane [MeSH Supplementary Concept]
- 6-chloro-5-(3'-hydroxycyclohexyl)indan-1-carboxylic acid [MeSH Supplementary Concept]
- 6-chloro-5-(4'-hydroxycyclohexyl)indan-1-carboxylic acid [MeSH Supplementary Concept]
- 6-chloro-5-(cyclopentylmethyl)indan-1-carboxylic acid [MeSH Supplementary Concept]
- 6-fluoroindan-1-acetic acid [MeSH Supplementary Concept]
- 6-methoxyindan-1-acetic acid [MeSH Supplementary Concept]
- 6-tert-butyl-1,1-dimethylindanyl [MeSH Supplementary Concept]
- 7a-methyl-5,6,7,7a-tetrahydroindan-1,5-dione-4- (3-propionic acid) [MeSH Supplementary Concept]
- 9,10-dioxoindano(2',3'-4,3)cyclobuta(1,2-b)indan-4b,4c-diyl diacetate [MeSH Supplementary Concept]
- A-395 compound [MeSH Supplementary Concept]
- AF 14049 [MeSH Supplementary Concept]
- Amplidione [MeSH Supplementary Concept]
- BEA 369 [MeSH Supplementary Concept]
- BL 2365 [MeSH Supplementary Concept]
- C-(4,5,6-trimethoxyindan-1-yl)methanamine [MeSH Supplementary Concept]
- DSKB-2 compound [MeSH Supplementary Concept]
- ELB00824 [MeSH Supplementary Concept]
- EN3427 [MeSH Supplementary Concept]
- HY 038 [MeSH Supplementary Concept]
- KR 62776 [MeSH Supplementary Concept]
- L 745337 [MeSH Supplementary Concept]
- L 754394 [MeSH Supplementary Concept]
- L 756423 [MeSH Supplementary Concept]
- LMP517 [MeSH Supplementary Concept]
- MRT199665 [MeSH Supplementary Concept]
- N,N-dimethyl-2-aminoindane [MeSH Supplementary Concept]
- N,N-dimethyl-3-(2',4'-dichlorophenyl)indanamine [MeSH Supplementary Concept]
- N,N-dimethyl-3-(4'-bromophenyl)-1-indanamine [MeSH Supplementary Concept]
- N,N-dimethyl-3-(4'-iodophenyl)-1-indanamine [MeSH Supplementary Concept]
- N-((1-oxoindan-4-yl)carbonyl)isoleucine methyl ester [MeSH Supplementary Concept]
- N-((3,5-difluoro-3'-(1H-1,2,4-triazol-3-yl)-4-biphenylyl)methyl)-2,3-dihydro-1H-inden-2-amine [MeSH Supplementary Concept]
- N-(6-(2,4-difluorophenoxy)indan-5-yl)methanesulfonamide [MeSH Supplementary Concept]
- N-(6-phenoxyindan-5-yl)methanesulfonamide [MeSH Supplementary Concept]
- N-(N-(1-carboxy-3-phenylpropyl)alanyl)-N-(indan-2-yl)glycine [MeSH Supplementary Concept]
- N-methyl-N-2-propynyl-1-indanamine [MeSH Supplementary Concept]
- N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride [MeSH Supplementary Concept]
- N1,N6-bis(2-hydroxy-1--indanyl)-2,5-bis(2,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide [MeSH Supplementary Concept]
- N1,N6-bis(2-hydroxy-1-indanyl)-2,5-bis(2,3-difluorobenzyloxy)-3,4-dihydroxyhexanediamide [MeSH Supplementary Concept]
- OPC 14117 [MeSH Supplementary Concept]
- PT2385 [MeSH Supplementary Concept]
- PT2399 [MeSH Supplementary Concept]
- QMF149 [MeSH Supplementary Concept]
- RP101075 [MeSH Supplementary Concept]
- RPR 112378 [MeSH Supplementary Concept]
- RPR 115781 [MeSH Supplementary Concept]
- RU 599 [MeSH Supplementary Concept]
- S 14905 [MeSH Supplementary Concept]
- SAR218645 [MeSH Supplementary Concept]
- SAR7334 [MeSH Supplementary Concept]
- SB 221420-A [MeSH Supplementary Concept]
- SB-699393 [MeSH Supplementary Concept]
- SDZ PRI 053 [MeSH Supplementary Concept]
- Uridion [MeSH Supplementary Concept]
- YZH-106 [MeSH Supplementary Concept]
- Z 335 [MeSH Supplementary Concept]
- acetyl tert-butyl dimethylindan [MeSH Supplementary Concept]
- aminoindanol [MeSH Supplementary Concept]
- aplykurodinone B [MeSH Supplementary Concept]
- aplykurodinone-1 [MeSH Supplementary Concept]
- benzo(f)-1-indanone [MeSH Supplementary Concept]
- bephedon [MeSH Supplementary Concept]
- bicyclo(4.3.0)nonane [MeSH Supplementary Concept]
- bindon [MeSH Supplementary Concept]
- biphenyl-indanone A [MeSH Supplementary Concept]
- bromindione [MeSH Supplementary Concept]
- camonagrel [MeSH Supplementary Concept]
- candoxatril [MeSH Supplementary Concept]
- cannabispiran [MeSH Supplementary Concept]
- caragasinin A [MeSH Supplementary Concept]
- chlorophacinone [MeSH Supplementary Concept]
- clidanac [MeSH Supplementary Concept]
- clorindione [MeSH Supplementary Concept]
- cyclo((2-methylamino-4,7-dimethoxyindan-2-carboxylic acid)(2-amino-4,7-dimethoxyindan-2-carboxylic acid)) [MeSH Supplementary Concept]
- dehydropterosin B [MeSH Supplementary Concept]
- delapril [MeSH Supplementary Concept]
- dietor [MeSH Supplementary Concept]
- difezon [MeSH Supplementary Concept]
- dinor-spiculoic acid A [MeSH Supplementary Concept]
- embellicine A [MeSH Supplementary Concept]
- embellicine B [MeSH Supplementary Concept]
- enrasentan [MeSH Supplementary Concept]
- fipamezole [MeSH Supplementary Concept]
- flosulide [MeSH Supplementary Concept]
- fluororasagiline [MeSH Supplementary Concept]
- fomajorin S [MeSH Supplementary Concept]
- homophthalaldehyde [MeSH Supplementary Concept]
- hydrindane [MeSH Supplementary Concept]
- hydrindantin [MeSH Supplementary Concept]
- indacaterol [MeSH Supplementary Concept]
- indacaterol acetate-mometasone furoate drug combination [MeSH Supplementary Concept]
- indacaterol-glycopyrronium combination [MeSH Supplementary Concept]
- indacrinone [MeSH Supplementary Concept]
- indan [MeSH Supplementary Concept]
- indanedioneketene [MeSH Supplementary Concept]
- indanestrol [MeSH Supplementary Concept]
- indanocine [MeSH Supplementary Concept]
- indanofan [MeSH Supplementary Concept]
- indanone oxime [MeSH Supplementary Concept]
- indanoxyacetic acid 94 [MeSH Supplementary Concept]
- indantadol [MeSH Supplementary Concept]
- indatraline [MeSH Supplementary Concept]
- iso-spiculoic acid A [MeSH Supplementary Concept]
- jiangxienone [MeSH Supplementary Concept]
- lu 19005 [MeSH Supplementary Concept]
- lycopoclavamine B [MeSH Supplementary Concept]
- lycoposerramine T [MeSH Supplementary Concept]
- manzamenone A [MeSH Supplementary Concept]
- methindione [MeSH Supplementary Concept]
- methyl-4,5-benzindan-2-carboxylate [MeSH Supplementary Concept]
- moskene [MeSH Supplementary Concept]
- nivimedone [MeSH Supplementary Concept]
- nor-spiculoic acid A [MeSH Supplementary Concept]
- octahydro-exo-4,7-methano-1H-indene [MeSH Supplementary Concept]
- org 10325 [MeSH Supplementary Concept]
- ozanimod [MeSH Supplementary Concept]
- perhydroindanpropionic acid [MeSH Supplementary Concept]
- peribysin E [MeSH Supplementary Concept]
- pestalachloride C [MeSH Supplementary Concept]
- phantolid [MeSH Supplementary Concept]
- phentolacin [MeSH Supplementary Concept]
- pindone [MeSH Supplementary Concept]
- pindone, warfarin drug combination [MeSH Supplementary Concept]
- prindamine [MeSH Supplementary Concept]
- ptaquiloside [MeSH Supplementary Concept]
- ptaquiloside Z [MeSH Supplementary Concept]
- pterosides [MeSH Supplementary Concept]
- pterosin [MeSH Supplementary Concept]
- pterosin A [MeSH Supplementary Concept]
- pterosin B [MeSH Supplementary Concept]
- pterosin Z [MeSH Supplementary Concept]
- radolmidine [MeSH Supplementary Concept]
- rasagiline [MeSH Supplementary Concept]
- ronacaleret [MeSH Supplementary Concept]
- sitolactone [MeSH Supplementary Concept]
- spiculoic acid A [MeSH Supplementary Concept]
- spiculoic acid B [MeSH Supplementary Concept]
- spiro((1,3-diazacyclopent-1-ene)-5 : 2'-(4',5'-dimethylindan)) fumarate [MeSH Supplementary Concept]
- spiro(cyclohexane-1,2'-indan)-1',4-dione [MeSH Supplementary Concept]
- spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one [MeSH Supplementary Concept]
- tripartin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients